Luyan Pharma Co.,Ltd. (SHE:002788)
China · Delayed Price · Currency is CNY 10.57
+0.37 (3.63%)
Aug 3, 2026, 3:05 PM CST
Luyan Pharma Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 21,424 | 21,247 | 20,471 | 19,846 | 19,463 | 17,545 |
Revenue Growth | 4.46% | 3.79% | 3.15% | 1.97% | 10.93% | 12.94% |
Gross Profit Gross Profit Growth | 1,495 | 1,497 | 1,523 | 1,506 | 1,512 | 1,366 |
Operating Income Operating Income Growth | 573.09 | 577.17 | 684.26 | 694.86 | 702.35 | 600.39 |
Net Income Net Income Growth | 277.5 | 280.88 | 345.64 | 363.53 | 345.16 | 305.87 |
Earnings Per Share EPS Growth | 0.71 | 0.72 | 0.89 | 0.94 | 0.89 | 0.79 |
EPS Growth | -16.45% | -19.10% | -5.32% | 5.62% | 12.66% | 6.76% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Wholesale of Medicine Wholesale of Medicine Growth | 19,114 | 18,587 | 18,249 | 18,192 | 16,496 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 1,517 | 1,193 | 1,042 | 847.42 | 719 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 558.61 | 618.17 | 493.9 | 366.7 | 293.18 |
Other Other Growth | 57.35 | 72.73 | 60.56 | 56.58 | 37.16 |
Total Total Growth | 21,247 | 20,471 | 19,846 | 19,463 | 17,545 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 555.93 | 616.96 | 576.85 | 606.3 | 594.19 | 415.43 |
Total Debt Total Debt Growth | 5,237 | 4,890 | 4,951 | 4,858 | 5,080 | 4,486 |
Net Cash (Debt) Net Cash Growth | -4,681 | -4,273 | -4,374 | -4,252 | -4,486 | -4,071 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -11.97 | -10.95 | -11.26 | -10.99 | -11.57 | -10.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 519.76 | 688.4 | 577.48 | 1,309 | 232.19 | -372.02 |
Capital Expenditures CapEx Growth | -211.73 | -233.74 | -361.12 | -529.21 | -327.58 | -243.49 |
Free Cash Flow Free Cash Flow Growth | 308.03 | 454.66 | 216.36 | 779.91 | -95.4 | -615.51 |
Free Cash Flow Growth | 3.46% | 110.14% | -72.26% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 6.98% | 7.05% | 7.44% | 7.59% | 7.77% | 7.79% |
Operating Margin | 2.67% | 2.72% | 3.34% | 3.50% | 3.61% | 3.42% |
Pretax Margin | 1.75% | 1.77% | 2.21% | 2.37% | 2.39% | 2.37% |
Profit Margin | 1.29% | 1.32% | 1.69% | 1.83% | 1.77% | 1.74% |
FCF Margin | 1.44% | 2.14% | 1.06% | 3.93% | -0.49% | -3.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.350 | 0.350 | 0.300 | 0.300 | 0.300 |
Dividend Per Share Growth | 0% | 0% | 16.67% | 0% | 0% | 50.00% |
Dividend Yield | 3.43% | 1.71% | 4.60% | 3.74% | 4.17% | 4.61% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.89 | 29.30 | 9.23 | 9.61 | 9.38 | 9.92 |
Forward PE | - | 7.62 | 7.62 | 8.48 | 11.00 | 9.52 |
P/FCF Ratio | 13.33 | 18.10 | 14.74 | 4.48 | - | - |
PS Ratio | 0.19 | 0.39 | 0.16 | 0.18 | 0.17 | 0.17 |